Pregabalin Attenuates Excitotoxicity in Diabetes

Chin Wei Huang, Ming Chi Lai, Juei Tang Cheng, Jing Jane Tsai, Chao Ching Huang, Sheng Nan Wu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Diabetes can exacerbate seizures and worsen seizure-related brain damage. In the present study, we aimed to determine whether the standard antiepileptic drug pregabalin (PGB) protects against pilocarpine-induced seizures and excitotoxicity in diabetes. Adult male Sprague-Dawley rats were divided into either a streptozotocin (STZ)-induced diabetes group or a normal saline (NS) group. Both groups were further divided into subgroups that were treated intravenously with either PGB (15 mg/kg) or a vehicle; all groups were treated with subcutaneous pilocarpine (60 mg/kg) to induce seizures. To evaluate spontaneous recurrent seizures (SRS), PGB-pretreated rats were fed rat chow containing oral PGB (450 mg) for 28 consecutive days; vehicle-pretreated rats were fed regular chow. SRS frequency was monitored for 2 weeks from post-status epilepticus day 15. We evaluated both acute neuronal loss and chronic mossy fiber sprouting in the CA3 area. In addition, we performed patch clamp recordings to study evoked excitatory postsynaptic currents (eEPSCs) in hippocampal CA1 neurons for both vehicle-treated rats with SRS. Finally, we used an RNA interference knockdown method for Kir6.2 in a hippocampal cell line to evaluate PGB's effects in the presence of high-dose ATP. We found that compared to vehicle-treated rats, PGB-treated rats showed less severe acute seizure activity, reduced acute neuronal loss, and chronic mossy fiber sprouting. In the vehicle-treated STZ rats, eEPSC amplitude was significantly lower after PGB administration, but glibenclamide reversed this effect. The RNA interference study confirmed that PGB could counteract the ATP-sensitive potassium channel (KATP)-closing effect of high-dose ATP. By opening KATP, PGB protects against neuronal excitotoxicity, and is therefore a potential antiepileptogenic in diabetes. These findings might help develop a clinical algorithm for treating patients with epilepsy and comorbid metabolic disorders.

Original languageEnglish
Article numbere65154
JournalPLoS One
Volume8
Issue number6
DOIs
Publication statusPublished - Jun 13 2013
Externally publishedYes

Fingerprint

seizures
Medical problems
diabetes
Rats
Seizures
rats
pilocarpine
Pilocarpine
Excitatory Postsynaptic Potentials
streptozotocin
Streptozocin
RNA Interference
sprouting
RNA interference
Prostaglandins B
Adenosine Triphosphate
RNA
anticonvulsants
glibenclamide
brain damage

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Huang, C. W., Lai, M. C., Cheng, J. T., Tsai, J. J., Huang, C. C., & Wu, S. N. (2013). Pregabalin Attenuates Excitotoxicity in Diabetes. PLoS One, 8(6), [e65154]. https://doi.org/10.1371/journal.pone.0065154

Pregabalin Attenuates Excitotoxicity in Diabetes. / Huang, Chin Wei; Lai, Ming Chi; Cheng, Juei Tang; Tsai, Jing Jane; Huang, Chao Ching; Wu, Sheng Nan.

In: PLoS One, Vol. 8, No. 6, e65154, 13.06.2013.

Research output: Contribution to journalArticle

Huang, CW, Lai, MC, Cheng, JT, Tsai, JJ, Huang, CC & Wu, SN 2013, 'Pregabalin Attenuates Excitotoxicity in Diabetes', PLoS One, vol. 8, no. 6, e65154. https://doi.org/10.1371/journal.pone.0065154
Huang CW, Lai MC, Cheng JT, Tsai JJ, Huang CC, Wu SN. Pregabalin Attenuates Excitotoxicity in Diabetes. PLoS One. 2013 Jun 13;8(6). e65154. https://doi.org/10.1371/journal.pone.0065154
Huang, Chin Wei ; Lai, Ming Chi ; Cheng, Juei Tang ; Tsai, Jing Jane ; Huang, Chao Ching ; Wu, Sheng Nan. / Pregabalin Attenuates Excitotoxicity in Diabetes. In: PLoS One. 2013 ; Vol. 8, No. 6.
@article{38fa441e9e1a411183be7f39aca71fe2,
title = "Pregabalin Attenuates Excitotoxicity in Diabetes",
abstract = "Diabetes can exacerbate seizures and worsen seizure-related brain damage. In the present study, we aimed to determine whether the standard antiepileptic drug pregabalin (PGB) protects against pilocarpine-induced seizures and excitotoxicity in diabetes. Adult male Sprague-Dawley rats were divided into either a streptozotocin (STZ)-induced diabetes group or a normal saline (NS) group. Both groups were further divided into subgroups that were treated intravenously with either PGB (15 mg/kg) or a vehicle; all groups were treated with subcutaneous pilocarpine (60 mg/kg) to induce seizures. To evaluate spontaneous recurrent seizures (SRS), PGB-pretreated rats were fed rat chow containing oral PGB (450 mg) for 28 consecutive days; vehicle-pretreated rats were fed regular chow. SRS frequency was monitored for 2 weeks from post-status epilepticus day 15. We evaluated both acute neuronal loss and chronic mossy fiber sprouting in the CA3 area. In addition, we performed patch clamp recordings to study evoked excitatory postsynaptic currents (eEPSCs) in hippocampal CA1 neurons for both vehicle-treated rats with SRS. Finally, we used an RNA interference knockdown method for Kir6.2 in a hippocampal cell line to evaluate PGB's effects in the presence of high-dose ATP. We found that compared to vehicle-treated rats, PGB-treated rats showed less severe acute seizure activity, reduced acute neuronal loss, and chronic mossy fiber sprouting. In the vehicle-treated STZ rats, eEPSC amplitude was significantly lower after PGB administration, but glibenclamide reversed this effect. The RNA interference study confirmed that PGB could counteract the ATP-sensitive potassium channel (KATP)-closing effect of high-dose ATP. By opening KATP, PGB protects against neuronal excitotoxicity, and is therefore a potential antiepileptogenic in diabetes. These findings might help develop a clinical algorithm for treating patients with epilepsy and comorbid metabolic disorders.",
author = "Huang, {Chin Wei} and Lai, {Ming Chi} and Cheng, {Juei Tang} and Tsai, {Jing Jane} and Huang, {Chao Ching} and Wu, {Sheng Nan}",
year = "2013",
month = "6",
day = "13",
doi = "10.1371/journal.pone.0065154",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Pregabalin Attenuates Excitotoxicity in Diabetes

AU - Huang, Chin Wei

AU - Lai, Ming Chi

AU - Cheng, Juei Tang

AU - Tsai, Jing Jane

AU - Huang, Chao Ching

AU - Wu, Sheng Nan

PY - 2013/6/13

Y1 - 2013/6/13

N2 - Diabetes can exacerbate seizures and worsen seizure-related brain damage. In the present study, we aimed to determine whether the standard antiepileptic drug pregabalin (PGB) protects against pilocarpine-induced seizures and excitotoxicity in diabetes. Adult male Sprague-Dawley rats were divided into either a streptozotocin (STZ)-induced diabetes group or a normal saline (NS) group. Both groups were further divided into subgroups that were treated intravenously with either PGB (15 mg/kg) or a vehicle; all groups were treated with subcutaneous pilocarpine (60 mg/kg) to induce seizures. To evaluate spontaneous recurrent seizures (SRS), PGB-pretreated rats were fed rat chow containing oral PGB (450 mg) for 28 consecutive days; vehicle-pretreated rats were fed regular chow. SRS frequency was monitored for 2 weeks from post-status epilepticus day 15. We evaluated both acute neuronal loss and chronic mossy fiber sprouting in the CA3 area. In addition, we performed patch clamp recordings to study evoked excitatory postsynaptic currents (eEPSCs) in hippocampal CA1 neurons for both vehicle-treated rats with SRS. Finally, we used an RNA interference knockdown method for Kir6.2 in a hippocampal cell line to evaluate PGB's effects in the presence of high-dose ATP. We found that compared to vehicle-treated rats, PGB-treated rats showed less severe acute seizure activity, reduced acute neuronal loss, and chronic mossy fiber sprouting. In the vehicle-treated STZ rats, eEPSC amplitude was significantly lower after PGB administration, but glibenclamide reversed this effect. The RNA interference study confirmed that PGB could counteract the ATP-sensitive potassium channel (KATP)-closing effect of high-dose ATP. By opening KATP, PGB protects against neuronal excitotoxicity, and is therefore a potential antiepileptogenic in diabetes. These findings might help develop a clinical algorithm for treating patients with epilepsy and comorbid metabolic disorders.

AB - Diabetes can exacerbate seizures and worsen seizure-related brain damage. In the present study, we aimed to determine whether the standard antiepileptic drug pregabalin (PGB) protects against pilocarpine-induced seizures and excitotoxicity in diabetes. Adult male Sprague-Dawley rats were divided into either a streptozotocin (STZ)-induced diabetes group or a normal saline (NS) group. Both groups were further divided into subgroups that were treated intravenously with either PGB (15 mg/kg) or a vehicle; all groups were treated with subcutaneous pilocarpine (60 mg/kg) to induce seizures. To evaluate spontaneous recurrent seizures (SRS), PGB-pretreated rats were fed rat chow containing oral PGB (450 mg) for 28 consecutive days; vehicle-pretreated rats were fed regular chow. SRS frequency was monitored for 2 weeks from post-status epilepticus day 15. We evaluated both acute neuronal loss and chronic mossy fiber sprouting in the CA3 area. In addition, we performed patch clamp recordings to study evoked excitatory postsynaptic currents (eEPSCs) in hippocampal CA1 neurons for both vehicle-treated rats with SRS. Finally, we used an RNA interference knockdown method for Kir6.2 in a hippocampal cell line to evaluate PGB's effects in the presence of high-dose ATP. We found that compared to vehicle-treated rats, PGB-treated rats showed less severe acute seizure activity, reduced acute neuronal loss, and chronic mossy fiber sprouting. In the vehicle-treated STZ rats, eEPSC amplitude was significantly lower after PGB administration, but glibenclamide reversed this effect. The RNA interference study confirmed that PGB could counteract the ATP-sensitive potassium channel (KATP)-closing effect of high-dose ATP. By opening KATP, PGB protects against neuronal excitotoxicity, and is therefore a potential antiepileptogenic in diabetes. These findings might help develop a clinical algorithm for treating patients with epilepsy and comorbid metabolic disorders.

UR - http://www.scopus.com/inward/record.url?scp=84878958100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878958100&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0065154

DO - 10.1371/journal.pone.0065154

M3 - Article

C2 - 23785408

AN - SCOPUS:84878958100

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e65154

ER -